Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug1268 | Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment Wiki | 0.71 |
| drug2026 | Isotretinoin(Aerosolized 13 cis retinoic acid) +standard treatment Wiki | 0.71 |
| drug688 | CD24Fc Wiki | 0.71 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D014456 | Ulcer NIH | 0.21 |
| D003092 | Colitis NIH | 0.21 |
| D003093 | Colitis, Ulcerative NIH | 0.21 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0002583 | Colitis HPO | 0.21 |
| HP:0100279 | Ulcerative colitis HPO | 0.21 |
| HP:0001370 | Rheumatoid arthritis HPO | 0.19 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0001369 | Arthritis HPO | 0.16 |
Navigate: Correlations HPO
There are 2 clinical trials
The primary objective of this study is to evaluate the effect of GLPG3970 compared to placebo on the signs and symptoms of Rheumatoid Arthritis (RA) in participants with moderately to severely active RA and an inadequate response to methotrexate (MTX).
The primary objective of this study is to evaluate the effect of GLPG3970 compared to placebo on the signs and symptoms of Ulcerative Colitis (UC) in participants with moderately to severely active UC.
Description: Mayo score is an instrument designed to measure disease activity of UC. Total Mayo score consists of 4 sub-scores: stool frequency, rectal bleeding, flexible sigmoidoscopy and physician's global assessment, each graded from 0 to 3. These scores are summed to give a total score range of 0 to 12, with higher total scores indicating more severe disease.
Measure: Change From Baseline in Total Mayo Clinical Score (MCS) at Week 6 Time: Baseline and Week 6Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports